Amgen, Ipsen vet moves up the ladder with Coherus’ anti-PD-1 awaiting PDUFA; It takes a village to replace Frank Clyburn at Merck’s Human Health business

February 18, 2022 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Amgen, Ipsen vet moves up the ladder with Coherus’ anti-PD-1 awaiting PDUFA; It takes a village to replace Frank Clyburn at Merck’s Human Health business
Paul Reider

After decades in the biopharma industry, Paul Reider is now in his first C-suite role as chief commercial officer. While he has been at Coherus BioSciences since last year, he officially started his new job on Jan. 1, and it was publicly announced on…